Can pharma legislation alone tackle rare diseases? Calls for EU-wide action abound

EU PERSPECTIVES - Only five per cent of rare diseases in Europe have an approved treatment. EU lawmakers face—and exert—growing pressure to fix deep gaps in access, incentives, and innovation with a European action plan. Read more

In need for Europe-wide coordination / Photo: Pixabay.com